ATRYS HEALTH (Germany) Performance
| A2T Stock | EUR 3.30 0.05 1.49% |
On a scale of 0 to 100, ATRYS HEALTH holds a performance score of 7. The firm shows a Beta (market volatility) of -0.59, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning ATRYS HEALTH are expected to decrease at a much lower rate. During the bear market, ATRYS HEALTH is likely to outperform the market. Please check ATRYS HEALTH's jensen alpha, sortino ratio, maximum drawdown, as well as the relationship between the total risk alpha and treynor ratio , to make a quick decision on whether ATRYS HEALTH's price patterns will revert.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in ATRYS HEALTH SA are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, ATRYS HEALTH reported solid returns over the last few months and may actually be approaching a breakup point. ...more
ATRYS |
ATRYS HEALTH Relative Risk vs. Return Landscape
If you would invest 290.00 in ATRYS HEALTH SA on November 29, 2024 and sell it today you would earn a total of 40.00 from holding ATRYS HEALTH SA or generate 13.79% return on investment over 90 days. ATRYS HEALTH SA is currently producing 0.2591% returns and takes up 2.8478% volatility of returns over 90 trading days. Put another way, 25% of traded stocks are less volatile than ATRYS, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
ATRYS HEALTH Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ATRYS HEALTH's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ATRYS HEALTH SA, and traders can use it to determine the average amount a ATRYS HEALTH's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.091
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | A2T | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.85 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.26 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average ATRYS HEALTH is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ATRYS HEALTH by adding it to a well-diversified portfolio.
ATRYS HEALTH Fundamentals Growth
ATRYS Stock prices reflect investors' perceptions of the future prospects and financial health of ATRYS HEALTH, and ATRYS HEALTH fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ATRYS Stock performance.
| EBITDA | 6.68 M | |||
| Cash And Equivalents | 17.6 M | |||
| Cash Per Share | 0.51 X | |||
| Total Debt | 71.4 M | |||
| Debt To Equity | 0.95 % | |||
| Book Value Per Share | 1.53 X | |||
| Cash Flow From Operations | (1.4 M) | |||
| Earnings Per Share | (0.05) X | |||
About ATRYS HEALTH Performance
By analyzing ATRYS HEALTH's fundamental ratios, stakeholders can gain valuable insights into ATRYS HEALTH's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ATRYS HEALTH has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ATRYS HEALTH has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain. ATRYS HEALTH is traded on Frankfurt Stock Exchange in Germany.Things to note about ATRYS HEALTH SA performance evaluation
Checking the ongoing alerts about ATRYS HEALTH for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ATRYS HEALTH SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Net Loss for the year was (2.02 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ATRYS HEALTH SA has accumulated about 17.6 M in cash with (1.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51. |
- Analyzing ATRYS HEALTH's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ATRYS HEALTH's stock is overvalued or undervalued compared to its peers.
- Examining ATRYS HEALTH's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ATRYS HEALTH's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ATRYS HEALTH's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ATRYS HEALTH's stock. These opinions can provide insight into ATRYS HEALTH's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ATRYS Stock analysis
When running ATRYS HEALTH's price analysis, check to measure ATRYS HEALTH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATRYS HEALTH is operating at the current time. Most of ATRYS HEALTH's value examination focuses on studying past and present price action to predict the probability of ATRYS HEALTH's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATRYS HEALTH's price. Additionally, you may evaluate how the addition of ATRYS HEALTH to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |